• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Fountain of Youth?





  • ~T~   May 06, 2014 at 05:41: PM
Makes a whole lot of sense. I want to get a transfusion of young blood now, lol.